11/6/2020 1:10:11 PM - Pulling back today after hitting a new 52-week high and challenging its all-time high ($54) with a streak of 4 consecutive volume-driven gains. The 11/05/20 mid-day report noted - "Completed new Public Offerings on 8/12/20 and 5/08/19. Fundamental concerns remain as 2 of the past 3 quarterly comparisons through Jun '20 were below the +25% minimum earnings guideline (C criteria). Went through a deep consolidation since dropped from the Featured Stocks list on 7/29/19."
11/5/2020 1:17:08 PM - Hitting a new 52-week high and challenging its all-time high ($54) with today's 4th consecutive volume-driven gain. Completed new Public Offerings on 8/12/20 and 5/08/19. Fundamental concerns remain as 2 of the past 3 quarterly comparisons through Jun '20 were below the +25% minimum earnings guideline (C criteria). Went through a deep consolidation since dropped from the Featured Stocks list on 7/29/19.
7/29/2019 5:39:40 PM - Abruptly retreated back below its 50 DMA line ($47.25) with today's reversal and big volume-driven loss hurting its outlook. Faces near-term resistance due to overhead supply up to the $54 level. Completed a new Public Offering on 5/08/19. Fundamentals have been strong. It will be dropped from the Featured Stocks list tonight.
7/26/2019 6:11:46 PM - G - Rebounded above its 50 DMA line ($47.38) with today's gain backed by light volume helping its outlook to improve. Faces near-term resistance due to overhead supply up to the $54 level. Completed a new Public Offering on 5/08/19. Fundamentals have been strong.
7/23/2019 5:34:33 PM - G - Toda it quietly slumped further below its 50 DMA line ($47.36) which has been acting as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
7/18/2019 3:57:54 PM - G - Quietly sputtering below its 50 DMA line ($47.33) which has been acting as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
7/12/2019 5:42:15 PM - G - Slumped for a 3rd consecutive loss today with light volume and its 50 DMA line ($47.27) has been acting as resistance. A rebound above the 50 DMA line is needed for its outlook to improve. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
7/8/2019 4:30:16 PM - G - Its 50 DMA line ($47.19) has been acting as resistance, meanwhile, a rebound above it is needed for its outlook to improve.Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
7/1/2019 1:23:02 PM - G - Halted its slide last week, however, a rebound above the 50 DMA line ($47.04) is needed for its outlook to improve. That important short-term average may act as resistance. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/28/2019 5:55:54 PM - G - Churned heavy volume today. A rebound above the 50 DMA line ($46.91) is needed for its outlook to improve. Recent losses completely negated the prior breakout from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/25/2019 2:16:07 PM - G - Color code is changed to green after violating its 50 DMA line ($46.72) with today's 4th consecutive loss raising concerns and triggering a technical sell signal. Recent losses completely negated the prior breakout from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/21/2019 6:08:35 PM - Y - Pulled back abruptly today nearly testing its 50 DMA line ($46.57) which defines near-term support to watch. Recent losses completely negated the prior breakout from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/17/2019 5:46:11 PM - Y - Posted a gain today with average volume for its second best close ever. Abruptly retreated into the prior base raising concerns with volume-driven losses last week. Its 50 DMA line ($45.87) defines near-term support to watch. Highlighted in yellow in the 6/10/19 mid-day report with pivot point cited based on its 5/17/19 high plus 10 cents as it rose from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/12/2019 5:30:08 PM - Y - Abruptly retreated with 2 volume-driven losses slumping back into the prior base and raising concerns. Near-term support to watch is at its 50 DMA line ($45.42). Highlighted in yellow in the 6/10/19 mid-day report with pivot point cited based on its 5/17/19 high plus 10 cents as it rose from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/12/2019 12:31:36 PM - Y - Abruptly retreated with 2 volume-driven losses slumping back into the prior base and raising concerns. Near-term support to watch is at its 50 DMA line ($45.40). Highlighted in yellow in the 6/10/19 mid-day report with pivot point cited based on its 5/17/19 high plus 10 cents as it rose from an advanced ascending base. Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria).
6/11/2019 1:06:13 PM - Y - Abruptly retreating today with volume running at a heavy pace. Highlighted in yellow in the prior mid-day report with pivot point cited based on its 5/17/19 high plus 10 cents. Rose from an advanced ascending base as a big volume-driven gain triggered a technical buy signal. Found support above its 50 DMA line ($45.30). Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria). See the latest FSU analysis for more details and an annotated graph.
6/10/2019 12:35:37 PM - Y - Color code is changed to yellow with pivot point cited based on its 5/17/19 high plus 10 cents after an advanced ascending base. Gapped up today with a big volume-driven gain triggering a technical buy signal. Found support above its 50 DMA line ($45.17). Completed a new Public Offering on 5/08/19. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria). After years of losses it had a profitable FY '16 and strong annual earnings (A criteria) growth. That helps it better match with the fact-based investment system's fundamental guidelines calling for 3-5 years of strong and steady earnings growth.
5/10/2019 1:25:00 PM - Completed a new Public Offering this week and found support above its 50 DMA line ($41.87). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria). After years of losses it had a profitable FY '16 and strong annual earnings (A criteria) growth. That helps it better match with the fact-based investment system's fundamental guidelines calling for 3-5 years of strong and steady earnings growth.
5/9/2019 1:19:01 PM - Extended from any sound base and enduring distributional pressure for the past week. Its 50 DMA line ($41.60) defines near-term support. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria). After years of losses it had a profitable FY '16 and strong annual earnings (A criteria) growth. That helps it better match with the fact-based investment system's fundamental guidelines calling for 3-5 years of strong and steady earnings growth.
5/7/2019 1:30:21 PM - Extended from any sound base and consolidating -9.5% off its 52-week high, encountering distributional pressure. Its 50 DMA line recently acted as support. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Quarterly comparisons through Mar '19 have shown impressive sales revenues growth and greatly improved earnings increases above the +25% minimum guideline (C criteria). After years of losses it had a profitable FY '16 and strong annual earnings (A criteria) growth. That helps it better match with the fact-based investment system's fundamental guidelines calling for 3-5 years of strong and steady earnings growth.
12/22/2017 1:05:28 PM - Consolidating -13.2% off its 52-week high, trading near its 50 and 200 DMA lines which recently acted as support. Quarterly comparisons through Sep '17 have shown impressive sales revenues acceleration and greatly improved earnings. After years of losses it had a profitable FY '16, however, its annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines calling for 3-5 years of strong and steady earnings growth.
4/17/2017 12:36:57 PM - Perched near its all-time high. Erratic quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines.